Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
Vet Rec. 2024 Jun 1;194(11):e4089. doi: 10.1002/vetr.4089. Epub 2024 May 29.
This study examined the experiences of owners of dogs with leishmaniosis who treated their dogs with daily subcutaneous meglumine antimoniate injections. The owners' perceived ease of administering the injections, the occurrence of problems and the effects on the owners and on the dog‒owner bond were evaluated.
Dogs prescribed meglumine antimoniate as a treatment for leishmaniosis were identified using the database of the veterinary pharmacy of the Faculty of Veterinary Medicine, Utrecht University. An online questionnaire was sent to the owners of these dogs to evaluate the perceived ease of administering the injections, the occurrence of problems and the effects on the owner and the dog-owner bond.
Responses were received from 64 dog owners. Most respondents (78%) reported that administering the injections was not difficult. Pain or the development of nodules at the injection site was reported in 50% and 40% of the dogs, respectively. Polyuria was reported in 44% of the dogs. Some owners reported that administering the injections had a negative impact on their psychological wellbeing (20%), and some would have liked more veterinary support (11%).
Some questions were answered by a limited number of people, and their responses may not be representative.
Dog owners remain highly motivated to persevere with meglumine antimoniate treatment and are willing to administer the injections themselves. The availability of active support when needed during the therapy cycle may further improve their acceptance of and confidence in giving the injections.
本研究调查了接受每日皮下注射盐酸氨苯砜治疗的犬利什曼病患者的主人的体验。评估了主人对注射的易感性、问题的发生以及对主人和主人与狗关系的影响。
使用乌得勒支大学兽医学院药房数据库确定了被开盐酸氨苯砜治疗利什曼病的狗。向这些狗的主人发送了在线问卷，以评估他们对注射的易感性、问题的发生以及对主人和主人与狗关系的影响。
收到了 64 名狗主人的回复。大多数受访者（78%）表示注射并不困难。分别有 50%和 40%的狗出现疼痛或注射部位出现结节。44%的狗出现多尿。一些主人报告说注射对他们的心理健康有负面影响（20%），一些主人希望得到更多的兽医支持（11%）。
有些问题的回答人数有限，他们的回答可能不具有代表性。
狗主人仍然非常有动力坚持使用盐酸氨苯砜治疗，并愿意自行注射。在治疗周期中需要时提供积极的支持，可能会进一步提高他们对注射的接受程度和信心。
